Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akso Health (AHG) Long-Term Deferred Tax (2017 - 2020)

Akso Health (AHG) has disclosed Long-Term Deferred Tax for 3 consecutive years, with $7.5 million as the latest value for Q1 2020.

  • For the quarter ending Q1 2020, Long-Term Deferred Tax rose 86.88% year-over-year to $7.5 million, compared with a TTM value of $7.5 million through Mar 2020, up 86.88%, and an annual FY2020 reading of $7.5 million, up 86.88% over the prior year.
  • Long-Term Deferred Tax was $7.5 million for Q1 2020 at Akso Health, up from $4.0 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $7.5 million in Q1 2020 and bottomed at $400062.0 in Q1 2017.
  • Average Long-Term Deferred Tax over 3 years is $4.0 million, with a median of $4.0 million recorded in 2019.
  • Peak annual rise in Long-Term Deferred Tax hit 86.88% in 2020, while the deepest fall reached 86.88% in 2020.
  • Year by year, Long-Term Deferred Tax stood at $400062.0 in 2017, then surged by 899.32% to $4.0 million in 2019, then soared by 86.88% to $7.5 million in 2020.
  • Business Quant data shows Long-Term Deferred Tax for AHG at $7.5 million in Q1 2020, $4.0 million in Q1 2019, and $400062.0 in Q1 2017.